Metastatic fibrolamellar hepatocellular carcinoma to the pancreas

Nicolas A. Villa, Rahul Pannala, Douglas O. Faigel, Danielle J. Haakinson, Nitin Katariya, Ramesh Ramanathan, Dawn Jaroszewski, Thomas K. Lidner, Thomas Byrne

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare variant of hepatocellular carcinoma, usually presenting in the younger population (<40 years) without underlying liver disease. Although it has a better prognosis than hepatocellular carcinoma, it has a high rate of recurrence months to years after primary resection. While sites of recurrence usually involve the liver, regional lymph nodes, peritoneum, and lung, metastasis to the pancreas is extremely rare, with only 2 other cases reported in the literature. We present the case of a 46-year-old patient with metastatic FL-HCC to the pancreas 30 years after diagnosis and 26 years since his last resected liver recurrence.

Original languageEnglish (US)
Pages (from-to)266-271
Number of pages6
JournalCase Reports in Gastroenterology
StatePublished - May 1 2015


  • Fibrolamellar hepatocellular carcinoma
  • Liver transplantation
  • Metastasis

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Metastatic fibrolamellar hepatocellular carcinoma to the pancreas'. Together they form a unique fingerprint.

Cite this